A Review on Treatment of Parkinson`S Disease

Parkinson’s disease is indeed a complex and progressive neurodegenerative disorder characterized by both motor and non-motor symptoms. Management focuses primarily on palliative care, aiming to enhance quality of life over the course of the disease, which can span several decades. Device-assisted therapies, such as deep brain stimulation, apomorphine pumps, and levodopa gel intestinal infusion, have revolutionized the treatment of advanced Parkinson's disease. These interventions can help manage motor fluctuations and improve overall function. Non-motor symptoms, including neuropsychiatric issues (like depression and anxiety), gastrointestinal problems, urogenital dysfunction, and sleep disturbances, are significant aspects of the disease. Remarkably, many of these symptoms can appear years before a formal diagnosis, underscoring the need for early recognition and comprehensive management strategies. Addressing these non-motor symptoms is crucial for improving patient care and support for those living with Parkinson's disease. Parkinson’s disease (PD) is indeed a significant neurodegenerative condition, typically manifesting between ages 55 and 65. The disease leads to a gradual worsening of both motor and non-motor symptoms, profoundly impacting quality of life.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-01-28
DOI
https://doi.org/10.5281/zenodo.14752422
Primary Topic
Information Systems Education and Curriculum Development
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review on Treatment of Parkinson`S Disease

Zenodo (CERN European Organization for Nuclear Research)
Information Systems Education and Curriculum Development
article

A Review on Treatment of Parkinson`S Disease

article en

Abstract

Parkinson’s disease is indeed a complex and progressive neurodegenerative disorder characterized by both motor and non-motor symptoms. Management focuses primarily on palliative care, aiming to enhance quality of life over the course of the disease, which can span several decades. Device-assisted therapies, such as deep brain stimulation, apomorphine pumps, and levodopa gel intestinal infusion, have revolutionized the treatment of advanced Parkinson's disease. These interventions can help manage motor fluctuations and improve overall function. Non-motor symptoms, including neuropsychiatric issues (like depression and anxiety), gastrointestinal problems, urogenital dysfunction, and sleep disturbances, are significant aspects of the disease. Remarkably, many of these symptoms can appear years before a formal diagnosis, underscoring the need for early recognition and comprehensive management strategies. Addressing these non-motor symptoms is crucial for improving patient care and support for those living with Parkinson's disease. Parkinson’s disease (PD) is indeed a significant neurodegenerative condition, typically manifesting between ages 55 and 65. The disease leads to a gradual worsening of both motor and non-motor symptoms, profoundly impacting quality of life.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 41%
Information Systems Education and Curriculum Development
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Review on Treatment of Parkinson`S Disease · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS